Association of glycemia and macrovascular and microvascular complications in type 2 diabetes (UKPDS 35): prospective observational study
Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycemia and macrovascular and microvascular complications in type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS [38]
UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS [38]. BMJ 317 (1998) 703-713
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomized controlled trials
Costa J., Borges M., David C., and Vaz Carneiro A. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomized controlled trials. BMJ 332 (2006) 1115-1124
Al-Nozha M.M., Al-Maatouq M.A., Al-Mazrou Y.Y., Al-Harthi S.S., Arafah M.R., Khalil M.Z., et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 25 (2004) 1603-1610
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
The diabetes quality improvement project moving science into health policy to gain an edge on the diabetes epidemic
Fleming B., Greenfield S., Engelgau M., Pogach L., Clauser S., and Parrott M. The diabetes quality improvement project moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24 (2001) 1815-1820